DOvEE

There has been no improvement in the cure rate of ovarian cancer in 30 years and this is unacceptable. If you look at a cell phone or computer from 30 years ago, today’s versions are tremendously different, and these types of advancements need to happen with respect to the early diagnosis of ovarian cancer.

Dr. Lucy Gilbert

Founder of the DOvEE project and Head of Gynecologic Oncology, MUHC

The Challenge

This year alone, 7,300 and 2,800 Canadian women will be diagnosed with endometrial and ovarian cancers respectively. Together, they are the third leading causes of cancer-related death in North American women. Ovarian cancer in particular is often called the silent killer because it can mimic other ailments until it is far too late. The good news is survival rates reach 80% when diagnosed in phase I and II. Sadly, 75% of ovarian cancers are diagnosed in phases III and IV, when the cancer has spread. Although early detection holds the key to improving survival rates for ovarian and endometrial cancers, there are currently no reliable screening tests to diagnose these two deadly types of cancers at their earliest possible stage.

The solution

The McGill University Health Centre’s (MUHC) Detecting Ovarian and Endometrial Cancer Early (DOvEE) project is the only one of its kind in the world.

Founded by Dr. Lucy Gilbert, she and her team of medical professionals are working to stop ovarian and endometrial cancers in their tracks by increasing the awareness of symptoms through satellite testing clinics around Montreal and offering free fast-tracked diagnostic testing to symptomatic women without a doctor’s referral.

Dr. Gilbert and her team have also pushed the early screening of ovarian and endometrial cancers one step further by developing a test that provides a safe and minimally invasive method to detect ovarian and endometrial cancers at an earlier stage than currently possible with existing tests, with the potential to increase survival rates.

In order for the DOvEE project to push the limits what’s possible, they must:

  • Continue to refine this novel and reliable screening test that will revolutionize the detection of ovarian and endometrial cancers, catching them at their earliest possible stages and improving survival rates
  • Conduct innovative research and clinical trials to better understand how ovarian and endometrial cancers start, grow, and spread
  • Make the new kit developed by the DOvEE team standard of care

How you can help

To allow Dr. Gilbert to apply for an available public grant, the MUHC Foundation has launched a $2 million Campaign. With this support, Dr. Gilbert and her team will conduct the necessary validation phase to get the DOvEEgene test approved as standard of care. The test will first be offered to Montreal women as part of the validation phase. Once approved, this test could be available throughout the world in GPs or Gynecologist offices saving millions of lives by diagnosing ovarian and endometrial cancers early, when they are most treatable.

For more information, to make a donation or to get involved, please contact Edith Bolduc, Development Officer, Major Gifts, 514-934-1934, ext. 34397, edith.bolduc@muhc.mcgill.ca

You can donate online, download our donation form or call us at 514-843-1543.

To make a gift in shares or mutual funds, please download this form.

DOvEE Campaign Co-chairs

DOvEE Campaign Co-chairs, from left: Micol Haimson, Matthew Marchand and Joanne Photiades

Joining us on this campaign are committee members:

  • Micol Haimson, Co-chair
  • Matthew Marchand, Co-chair
  • Joanne Photiades, Co-chair
  • Valerie Aitken
  • Pam Brydges
  • Shellie Feldman
  • Bonnie Fletcher
  • Justine Frangouli-Argyris
  • Paula Gillett
  • Catherine Heaton
  • Anne Lafleur
  • Houda Moussalier
  • Marissa Nuss

Follow Us

LEAP has selected Centre universitaire de santé McGill - McGill University Health Centre cardiologist & Research Institute of the McGill University Health Centre researcher, Dr. Abhinav Sharma’s, MyHeart Counts Canada mobile application for their Healthy Future Accelerator. MyHeart Counts Canada’s goal is to get Canadians moving for improved cardiovascular health. Dr. Sharma’s app uses artificial-intelligence with real-time feedback and support to improve physical activity incrementally. LEAP is donating $100, 000 to support the continued development of Dr. Sharma’s app through the MUHC Foundation’s Fix Broken Hearts campaign. Watch: 📺 youtu.be/GG2HKWxVfxA

LEAP a choisi l'application mobile MyHeart Counts Canada du Dr Abhinav Sharma, cardiologue du CUSM et chercheur de l'IR-CUSM, pour leur accélérateur Horizons Santé. L’objectif de MyHeart Counts Canada est de faire bouger les Canadiens pour une meilleure santé cardiovasculaire. L'application mobile du Dr Sharma utilise l'intelligence artificielle avec rétroaction et l’assistance en temps réel pour améliorer progressivement l'activité physique. LEAP fait un don de 100 000 $ pour soutenir le développement continu de l'application du Dr Sharma dans le cadre de la campagne Souder les cœurs brisés de la Fondation du CUSM.
... See MoreSee Less

View on Facebook

Ce « Mardi je donne » est presque terminé! ⏰ Pour chaque femme dont la vie a été anéantie par le cancer de l’ovaire ou de l’endomètre. Pour chaque mère qui ne verra pas ses enfants grandir en raison de ces maladies. Pour chaque femme qui lutte actuellement pour sa vie, unissons-nous comme jamais auparavant. ❤️ The DOVEE Project

✨ Faites un don: bit.ly/3pIj2vZ

#MardiJeDonne #OsezRêverFCUSM

Giving Tuesday is nearing its end!⏱ For every woman whose life has been cut short because of ovarian or endometrial cancers. For every mother who won’t see her children grow up because of these diseases. For every woman fighting for her life right now, let’s come together like never before.

✨Donate: bit.ly/38Vtb2o

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Let’s do this, Montreal—we’re more than halfway through Giving Tuesday and we need every one of you to help us reach our $70,000 goal. 🙌 Support Dr. Gilbert, Joanne, Lawrie and the entire The DOVEE Project's Giving Tuesday dream of stopping ovarian and endometrial cancers. Combined, more than 3,000 Canadian women die each year from these cancers—but it doesn’t have to be this way. Let’s stop these deadly killers, once and for all.

✨ Donate now: bit.ly/3nREEEz

Plus de 3 000 Canadiennes succombent chaque année à ces deux cancers, mais nous pouvons les sauver. Arrêtons ces tueurs silencieux, une fois pour toutes.

✨Faites un don: bit.ly/2ISbhCC

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

À l’occasion de « Mardi je donne », votre contribution sera égalée jusqu’à concurrence de 50 000 $ grâce à la générosité d’un grand donateur anonyme! La Dre Gilbert et ses collègues Centre universitaire de santé McGill - McGill University Health Centre ont mis au point un test sécuritaire et moins invasif qui permet de dépister les cancers de l’ovaire et de l’endomètre de façon plus précoce que jamais auparavant.

✨ Faites un don: bit.ly/38UHcgN
---
It's Giving Tuesday, and your donation today will be doubled up to $50,000 thanks to a generous anonymous donor. Dr. Gilbert and her colleagues @ The DOVEE Project have developed a test that offers a safe, less invasive way to detect ovarian and endometrial cancers earlier than ever before. The answer for moving this test into clinical implementation? Generous Giving Tuesday supporters like you. ❤️

✨ Donate now: bit.ly/2UEAgvY

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Demain, c’est la journée « Mardi je donne ». Voici un message important de Lawrie Shahbazian, une coordonnatrice du projet DOvEEgene The DOVEE Project

« Les femmes qui reçoivent un diagnostic de cancer de l’ovaire ou de l’endomètre se posent souvent cette question : ‘ J’ai pris soin de ma santé. J’ai passé les examens, les tests Pap et les mammographies. Qu’est-ce que j’aurais pu faire de plus?’ La réponse, c’est DOvEEgene. Notre test minimalement invasif fonctionne, ici et maintenant. Nous en sommes à la dernière étape de notre marathon, le passage aux essais cliniques de stade trois. En tant que jeune femme, je compte bien voir les résultats et les bienfaits de notre travail acharné de mon vivant. Avec votre aide, nous sauverons des vies.”

✨Faites un don: bit.ly/3l1xQ53
... See MoreSee Less

View on Facebook